StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bone Biologics's operating income for the twelve months ending Sep 30, 2026 was -$3.01M. For fiscal 2025 it was -$3.23M. The highest annual figure on record is -$825.01K in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.23M–
FY2024Dec 31, 2024-$4.22M–
FY2023Dec 31, 2023-$9.43M–
FY2022Dec 31, 2022-$3.67M–
FY2021Dec 31, 2021-$1.10M–
FY2020Dec 31, 2020-$825.01K–
FY2019Dec 31, 2019-$2.45M–
FY2018Dec 31, 2018-$2.79M–
FY2017Dec 31, 2017-$2.63M–
FY2016Dec 31, 2016-$20.41M–
FY2015Dec 31, 2015-$12.00M–
FY2014Dec 31, 2014-$3.01M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$666.34K–
Q2 FY2026Jun 30, 2026-$808.11K–
Q1 FY2026Mar 31, 2026-$805.05K–
Q4 FY2025Dec 31, 2025-$733.11K–
Q3 FY2025Sep 30, 2025-$715.27K–
Q2 FY2025Jun 30, 2025-$748.08K–
Q1 FY2025Mar 31, 2025-$1.04M–
Q4 FY2024Dec 31, 2024-$1.55M–
Q3 FY2024Sep 30, 2024-$951.02K–
Q2 FY2024Jun 30, 2024-$809.67K–
Q1 FY2024Mar 31, 2024-$903.54K–
Q4 FY2023Dec 31, 2023-$1.16M–
Q3 FY2023Sep 30, 2023-$2.08M–
Q2 FY2023Jun 30, 2023-$3.04M–
Q1 FY2023Mar 31, 2023-$3.15M–
Q2 FY2022Jun 30, 2022-$469.30K–
Q1 FY2022Mar 31, 2022-$689.50K–
Q4 FY2021Dec 31, 2021-$460.48K–
Q3 FY2021Sep 30, 2021-$229.79K–
Q2 FY2021Jun 30, 2021-$231.88K–
Q1 FY2021Mar 31, 2021-$180.92K–
Q4 FY2020Dec 31, 2020-$206.43K–
Q3 FY2020Sep 30, 2020-$145.82K–
Q2 FY2020Jun 30, 2020-$132.71K–
Q1 FY2020Mar 31, 2020-$340.05K–
Q4 FY2019Dec 31, 2019-$277.63K–
Q3 FY2019Sep 30, 2019-$301.31K-174.4%
Q2 FY2019Jun 30, 2019-$679.26K–
Q1 FY2019Mar 31, 2019-$1.19M–
Q4 FY2018Dec 31, 2018-$1.24M–
Q3 FY2018Sep 30, 2018$404.79K–
Q2 FY2018Jun 30, 2018-$860.15K-143.6%
Q1 FY2018Mar 31, 2018-$1.10M–
Q4 FY2017Dec 31, 2017-$1.31M–
Q3 FY2017Sep 30, 2017-$1.13M–
Q2 FY2017Jun 30, 2017$1.97M–
Q1 FY2017Mar 31, 2017-$2.16M–
Q4 FY2016Dec 31, 2016-$3.11M–
Q3 FY2016Sep 30, 2016-$3.86M–

More Bone Biologics figures

See a number that looks wrong?